BRAF and colorectal cancer: Although we conducted four human colorectal cancer cell lines in this experiments, did not confirm other human colorectal cancer cell lines harboring KRAS, BRAF and PIK3CA mutation and patients-derived MEK inhibitor resistance colorectal cancer cells.